Abigail B. Shoben
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Abigail B. Shoben has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Randi E. Foraker
University of Missouri Columbia Health Care: MU Health Care
3 shared publications - Albert M. Lai
Institute for Informatics, Data Science, and Biostatistics, Washington University School of Medicine, St. Louis, MO, USA
2 shared publications Bryan Kestenbaum
Kidney Research Institute, University of Washington, Seattle, WA
2 shared publicationsGregory Levin
Department of Biostatistics, University of Washington, Seattle, WA
2 shared publicationsIan H. de Boer
Kidney Research Institute, University of Washington, Seattle, WA
2 shared publications- Michael A. Langan
The Ohio State University College of Medicine, Columbus, OH 43210, United States
2 shared publications
Latest Publications
- Open Access
- 1 December 2016
- Published by Elsevier in Preventive Medicine Reports
- Vol. 4, 303-308
Electronic health record-based assessment of cardiovascular health: The stroke prevention in healthcare delivery environments (SPHERE) study
- 1 December 2016
- Published by Elsevier in Preventive Medicine Reports
- Vol. 4, 303-308
Open AccessElectronic health record-based assessment of cardiovascular health: The stroke prevention in healthcare delivery environments (SPHERE) study
- 1 July 2016
- Published by Elsevier in American Heart Journal
- Vol. 177, 25-32
Comparison of risk scores for the prediction of stroke in African Americans: Findings from the Jackson Heart Study
- 1 July 2016
- Published by Elsevier in American Heart Journal
- Vol. 177, 25-32
Comparison of risk scores for the prediction of stroke in African Americans: Findings from the Jackson Heart Study
- 9 June 2016
- Published by Taylor & Francis in Journal of Biopharmaceutical Statistics
- Vol. 27  (1) , 135-147
More data, less information? Potential for nonmonotonic information growth using GEE
Statistical intuition suggests that increasing the total number of observations available for analysis should increase the precision with which parameters can be estimated. Such monotonic growth of statistical information is of particular importance when data are analyzed sequentially, such as in confirmatory clinical trials. However, monotonic information growth is not always guaranteed, even when using a valid, but inefficient estimator. In this article, we demonstrate the theoretical possibility of nonmonotonic information growth when using generalized estimating equations (GEE) to estimate a slope and provide intuition for why this possibility exists. We use theoretical and simulation-based results to characterize situations that may result in nonmonotonic information growth. Nonmonotonic information growth is most likely to occur when (1) accrual is fast relative to follow-up on each individual, (2) correlation among measurements from the same individual is high, and (3) measurements are becoming more variable further from randomization. In situations that may lead to nonmonotonic information growth, study designers should plan interim analyses to avoid situations most likely to result in nonmonotonic information growth.
- 9 June 2016
- Published by Taylor & Francis in Journal of Biopharmaceutical Statistics
- Vol. 27  (1) , 135-147
More data, less information? Potential for nonmonotonic information growth using GEE
Statistical intuition suggests that increasing the total number of observations available for analysis should increase the precision with which parameters can be estimated. Such monotonic growth of statistical information is of particular importance when data are analyzed sequentially, such as in confirmatory clinical trials. However, monotonic information growth is not always guaranteed, even when using a valid, but inefficient estimator. In this article, we demonstrate the theoretical possibility of nonmonotonic information growth when using generalized estimating equations (GEE) to estimate a slope and provide intuition for why this possibility exists. We use theoretical and simulation-based results to characterize situations that may result in nonmonotonic information growth. Nonmonotonic information growth is most likely to occur when (1) accrual is fast relative to follow-up on each individual, (2) correlation among measurements from the same individual is high, and (3) measurements are becoming more variable further from randomization. In situations that may lead to nonmonotonic information growth, study designers should plan interim analyses to avoid situations most likely to result in nonmonotonic information growth.
- 15 February 2016
- Published by Springer Nature in Journal of Community Health
- Vol. 41  (5) , 897-902
Energy Drink Use Among Ohio Appalachian Smokers
Caffeine-containing energy drinks have emerged as a public health concern due to their association with caffeine toxicity and alcohol use. Despite the fact that previous research has linked caffeine use in the form of coffee drinking to smoking, there is little research examining the association between energy drinks and smoking. The present study examines demographic and behavioral factors associated with energy drink use among a sample of rural Ohio Appalachian smokers. It was hypothesized that male gender, young age (21–30 years.) and alcohol use would be associated with energy drink use. A sample of adult smokers (n = 298) from Ohio Appalachian counties were interviewed regarding demographic and behavioral factors. Logistic regression analysis was used to assess the association between these factors and energy drink use. Seventy percent of Ohio Appalachian smokers studied had ever used an energy drink and 40 % had used an energy drink in the past month. Young age, male gender, and single marital status were associated with higher odds of ever having used an energy drink. Young age, and binge drinking were associated with higher odds of past 30-day use while abstinence from drinking was associated with lower odds of past 30-day use. Ohio Appalachian adult smokers had higher rates of energy drink use compared to previous estimates of ever or past month use found in other studies. The combined use of caffeine, nicotine, and alcohol warrants attention due to potential for health risk.
- 15 February 2016
- Published by Springer Nature in Journal of Community Health
- Vol. 41  (5) , 897-902
Energy Drink Use Among Ohio Appalachian Smokers
Caffeine-containing energy drinks have emerged as a public health concern due to their association with caffeine toxicity and alcohol use. Despite the fact that previous research has linked caffeine use in the form of coffee drinking to smoking, there is little research examining the association between energy drinks and smoking. The present study examines demographic and behavioral factors associated with energy drink use among a sample of rural Ohio Appalachian smokers. It was hypothesized that male gender, young age (21–30 years.) and alcohol use would be associated with energy drink use. A sample of adult smokers (n = 298) from Ohio Appalachian counties were interviewed regarding demographic and behavioral factors. Logistic regression analysis was used to assess the association between these factors and energy drink use. Seventy percent of Ohio Appalachian smokers studied had ever used an energy drink and 40 % had used an energy drink in the past month. Young age, male gender, and single marital status were associated with higher odds of ever having used an energy drink. Young age, and binge drinking were associated with higher odds of past 30-day use while abstinence from drinking was associated with lower odds of past 30-day use. Ohio Appalachian adult smokers had higher rates of energy drink use compared to previous estimates of ever or past month use found in other studies. The combined use of caffeine, nicotine, and alcohol warrants attention due to potential for health risk.
- Open Access
- 18 June 2015
- Published by Ubiquity Press, Ltd. in eGEMs (Generating Evidence & Methods to improve patient outcomes)
- Vol. 3  (2) , 1159
EHR-based Visualization Tool: Adoption Rates, Satisfaction, and Patient Outcomes
Background: Electronic health records (EHRs) have the potential to enhance patient-provider communication and improve patient outcomes. However, in order to impact patient care, clinical decision support (CDS) and communication tools targeting such needs must be integrated into clinical workflow and be flexible with regard to the changing health care landscape.Design: The Stroke Prevention in Healthcare Delivery Environments (SPHERE) team developed and implemented the SPHERE tool, an EHR-based CDS visualization, to enhance patient-provider communication around cardiovascular health (CVH) within an outpatient primary care setting of a large academic medical center.Implementation: We describe our successful CDS alert implementation strategy and report adoption rates. We also present results of a provider satisfaction survey showing that the SPHERE tool delivers appropriate content in a timely manner. Patient outcomes following implementation of the tool indicate one-year improvements in some CVH metrics, such as body mass index and diabetes.Discussion: Clinical decision-making and practices change rapidly and in parallel to simultaneous changes in the health care landscape and EHR usage. Based on these observations and our preliminary results, we have found that an integrated, extensible, and workflow-aware CDS tool is critical to enhancing patient-provider communications and influencing patient outcomes.
- 18 June 2015
- Published by Ubiquity Press, Ltd. in eGEMs (Generating Evidence & Methods to improve patient outcomes)
- Vol. 3  (2) , 1159
Open AccessEHR-based Visualization Tool: Adoption Rates, Satisfaction, and Patient Outcomes
Background: Electronic health records (EHRs) have the potential to enhance patient-provider communication and improve patient outcomes. However, in order to impact patient care, clinical decision support (CDS) and communication tools targeting such needs must be integrated into clinical workflow and be flexible with regard to the changing health care landscape.Design: The Stroke Prevention in Healthcare Delivery Environments (SPHERE) team developed and implemented the SPHERE tool, an EHR-based CDS visualization, to enhance patient-provider communication around cardiovascular health (CVH) within an outpatient primary care setting of a large academic medical center.Implementation: We describe our successful CDS alert implementation strategy and report adoption rates. We also present results of a provider satisfaction survey showing that the SPHERE tool delivers appropriate content in a timely manner. Patient outcomes following implementation of the tool indicate one-year improvements in some CVH metrics, such as body mass index and diabetes.Discussion: Clinical decision-making and practices change rapidly and in parallel to simultaneous changes in the health care landscape and EHR usage. Based on these observations and our preliminary results, we have found that an integrated, extensible, and workflow-aware CDS tool is critical to enhancing patient-provider communications and influencing patient outcomes.
- 13 May 2015
- Published by Springer Nature in Administration and Policy in Mental Health and Mental Health Services Research
- Vol. 43  (4) , 524-534
A Comparison of Benefit Limits in Mental Health
- 13 May 2015
- Published by Springer Nature in Administration and Policy in Mental Health and Mental Health Services Research
- Vol. 43  (4) , 524-534
A Comparison of Benefit Limits in Mental Health
- 16 September 2014
- Published by Wiley in Statistics in Medicine
- Vol. 33  (29) , 5041-5056
Violations of the independent increment assumption when using generalized estimating equation in longitudinal group sequential trials
In phase 3 clinical trials, ethical and financial concerns motivate sequential analyses in which the data are analyzed prior to completion of the entire planned study. Existing group sequential software accounts for the effects of these interim analyses on the sampling density by assuming that the contribution of subsequent increments is independent of the contribution from previous data. This independent increment assumption is satisfied in many common circumstances, including when using the efficient estimator. However, certain circumstances may dictate using an inefficient estimator, and the independent increment assumption may then be violated. Consequences of assuming independent increments in a setting where the assumption does not hold have not been previously explored. One important setting in which independent increments may not hold is the setting of longitudinal clinical trials. This paper considers dependent increments that arise because of heteroscedastic and correlated data in the context of longitudinal clinical trials that use a generalized estimating equation (GEE) approach. Both heteroscedasticity over time and correlation of observations within subjects may lead to departures from the independent increment assumption when using GEE. We characterize situations leading to greater departures in this paper. Despite violations of the independent increment assumption, simulation results suggest that operating characteristics of sequential designs are largely maintained for typically observed patterns of accrual, correlation, and heteroscedasticity even when using analyses that use standard software that depends on an independent increment structure. More extreme scenarios may require greater care to avoid departures from the nominal type I error rate and power. Copyright © 2014 John Wiley & Sons, Ltd.
- 16 September 2014
- Published by Wiley in Statistics in Medicine
- Vol. 33  (29) , 5041-5056
Violations of the independent increment assumption when using generalized estimating equation in longitudinal group sequential trials
In phase 3 clinical trials, ethical and financial concerns motivate sequential analyses in which the data are analyzed prior to completion of the entire planned study. Existing group sequential software accounts for the effects of these interim analyses on the sampling density by assuming that the contribution of subsequent increments is independent of the contribution from previous data. This independent increment assumption is satisfied in many common circumstances, including when using the efficient estimator. However, certain circumstances may dictate using an inefficient estimator, and the independent increment assumption may then be violated. Consequences of assuming independent increments in a setting where the assumption does not hold have not been previously explored. One important setting in which independent increments may not hold is the setting of longitudinal clinical trials. This paper considers dependent increments that arise because of heteroscedastic and correlated data in the context of longitudinal clinical trials that use a generalized estimating equation (GEE) approach. Both heteroscedasticity over time and correlation of observations within subjects may lead to departures from the independent increment assumption when using GEE. We characterize situations leading to greater departures in this paper. Despite violations of the independent increment assumption, simulation results suggest that operating characteristics of sequential designs are largely maintained for typically observed patterns of accrual, correlation, and heteroscedasticity even when using analyses that use standard software that depends on an independent increment structure. More extreme scenarios may require greater care to avoid departures from the nominal type I error rate and power. Copyright © 2014 John Wiley & Sons, Ltd.
- Open Access
- 1 March 2014
- Published by Elsevier in Contemporary Clinical Trials
- Vol. 37  (2) , 284-293
Teaching tobacco dependence treatment and counseling skills during medical school: Rationale and design of the Medical Students helping patients Quit tobacco (MSQuit) group randomized controlled trial
- 1 March 2014
- Published by Elsevier in Contemporary Clinical Trials
- Vol. 37  (2) , 284-293
Open AccessTeaching tobacco dependence treatment and counseling skills during medical school: Rationale and design of the Medical Students helping patients Quit tobacco (MSQuit) group randomized controlled trial
- 16 August 2013
- Published by Taylor & Francis in The American Journal of Bioethics
- Vol. 13  (9) , 15-7
The value of sound research practices even facing pandemics.
- 16 August 2013
- Published by Taylor & Francis in The American Journal of Bioethics
- Vol. 13  (9) , 15-7
The value of sound research practices even facing pandemics.
- 1 May 2012
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 59  (5) , 645-652
Variation in Oral Calcitriol Response in Patients With Stages 3-4 CKD
- 1 May 2012
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 59  (5) , 645-652
Variation in Oral Calcitriol Response in Patients With Stages 3-4 CKD